U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07229807) titled 'Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza A' on Nov. 13.
Brief Summary: This trial is conducted in China. The aim of the trial is to investigate safety and efficacy of ZSP1273 granules
Study Start Date: Nov. 30
Study Type: INTERVENTIONAL
Condition:
Influenza a
Intervention:
DRUG: ZSP1273
Oral
DRUG: Oseltamivir
Oral
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Guangdong Raynovent Biotech Co., Ltd
Disclaimer: Curated by HT Syndication....